Abstract
Flu is a serious health, medical, and economic problem, but no therapy is yet available that has satisfactory results and reduces the occurrence of these problems. Nearly 20 years after the registration of the previous therapy, baloxavir marboxil, a drug with a new mechanism of action, recently appeared on the market. This is a promising step in the fight against the influenza virus. This article presents the possibilities of using all available antiviral drugs specific for influenza A and B. We compare all currently recommended anti-influenza medications, considering their mechanisms of action, administration, indications, target groups, effectiveness, and safety profiles. We demonstrate that baloxavir marboxil presents a similar safety and efficacy profile to those of drugs already used in the treatment of influenza. Further research on combination therapy is highly recommended and may have promising results.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference153 articles.
1. Seasonal Influenza (Flu)
2. Influenza
https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccines-quality/influenza
3. Estimate of Influenza Deaths Due to Respiratory Disease
https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/burden-of-disease
4. Economic burden of seasonal influenza in the United States
5. Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献